NASDAQ: ENTAEnanta Pharmaceuticals Inc Stock Ownership - Who owns Enanta Pharmaceuticals?
Insider buying vs selling
Have Enanta Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Scott T. Rottinghaus | Chief Medical Officer | 2025-02-12 | 2,861 | $5.59 | $15.99kSell |
| Tara Lynn Kieffer | Chief Product Strategy Officer | 2025-02-12 | 3,326 | $5.59 | $18.59kSell |
| Jay R. Luly | President and CEO | 2025-02-12 | 45,000 | $5.69 | $256.05kBuy |
| Jay R. Luly | President and CEO | 2025-02-12 | 7,484 | $5.59 | $41.84kSell |
| Brendan Luu | Chief Business Officer | 2025-02-12 | 3,326 | $5.59 | $18.59kSell |
| Paul J. Mellett | Chief Fin. Admin Officer | 2025-02-12 | 3,326 | $5.59 | $18.59kSell |
| Yat Sun Or | Chief Scientific Officer | 2025-02-12 | 4,324 | $5.59 | $24.17kSell |
| Tara Lynn Kieffer | Chief Product Strategy Officer | 2024-12-06 | 2,283 | $8.06 | $18.40kSell |
| Yat Sun Or | Chief Scientific Officer | 2024-12-06 | 2,591 | $8.06 | $20.88kSell |
| Brendan Luu | Chief Business Officer | 2024-12-06 | 2,283 | $8.06 | $18.40kSell |
ENTA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ENTA insiders and whales buy or sell their stock.
ENTA Shareholders
What type of owners hold Enanta Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Helmut Schuhsler | 26.95% | 5,761,609 | $37.80M | Insider |
| Saints Capital Granite LP | 16.36% | 3,497,683 | $22.94M | Insider |
| Farallon Capital Management LLC | 9.93% | 2,122,262 | $13.92M | Institution |
| Krensavage Asset Management LLC | 9.90% | 2,116,586 | $13.88M | Institution |
| Blackrock Inc | 9.44% | 2,018,669 | $13.24M | Institution |
| Vanguard Group Inc | 9.39% | 2,007,433 | $13.17M | Institution |
| Shionogi Co Ltd | 7.48% | 1,599,760 | $10.49M | Insider |
| Millennium Management LLC | 6.30% | 1,346,932 | $8.84M | Institution |
| Tvm V Life Science Ventures Gmbh Co Kg | 5.36% | 1,144,932 | $7.51M | Insider |
| Acadian Asset Management LLC | 4.06% | 867,037 | $5.69M | Institution |
ENTA vs Biotech Stocks
Enanta Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.